Poster title: MYLOX-1: An Open-Label, Phase IIa Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Oral LOXL2 Inhibitor, GB2064, in Myelofibrosis: Intermediate Assessment
Poster audio recording: MYLOX-1: An Open-Label, Phase IIa Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Oral LOXL2 Inhibitor, GB2064, in Myelofibrosis: Intermediate Assessment
https://www.hematology.org/meetings/annual-meeting